Depression and Fatigue in MS Patients Treated With Betaferon.

CompletedOBSERVATIONAL

Enrollment

567

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions

Multiple Sclerosis

Interventions

BIOLOGICAL

Interferon beta-1b (Betaferon, BAY86-5046)

Patients treated with regular dose of Betaferon injections (250 micrograms subcutaneously every other day) under routine practice setting.

Trial Locations (1)

Many Locations